A Few Words

About HGI Group

HGI Clinical is a privately held Texas CRO serving small to mid-size biotech and pharma clients. Located in the TMC Innovation Factory, HGI Clinical proudly supports many early phase drug development programs.

Early days of clinical trial development can seem like a daunting task, but HGI Clinical has a solution for each stage of development, operational planning and subsequent implementation. Whether you need support with pre-IND planning, discovery, protocol/ trial feasibility, site identification, study start-up forecasting, clinical monitoring, TMF management, negotiation of site agreement , vendor oversight or project management, we have a solution for you. Our priority is to provide quality clinical trial resources who are focused on achieving your study milestones.

Our team of trusted advisors and leadership works seamlessly with our clients to thoroughly understand the intricacies of your clinical trial and long-term goals. An integrated working relationship enables us to not only assist our clients with the challenges of a competitive marketplace, but also provide strategic and tailored solutions and staff.

Our services are specifically designed to provide quality input to our clients and their trials, with a major focus on the eventual trial participants. With those goals in mind, we develop a flexible  solution for our customers and their unique requirements.

We truly believe that scientific advancement is only achieved through the collaboration of strong team members, and that is at the epicenter of our culture.

Who We Are

HGI Clinical is a relationship focused CRO with not only a wide range of therapeutic experience, but also experience with investigational product types, study designs and operational strategies.

Our highly experienced team has participated in 100s of clinical trials over the years and bring an average of 15 years in the clinical trial industry. Those efforts have supported numerous biotech/pharma clients, many of whom conduct early phase, complex , and oncology focused trials.

Scroll to Top